[ad_1]
You may need to turn your volume up on this presentation
DOWNLOAD FOR FREE AT PODOMATIC
https://www.podomatic.com/podcasts/karmakoalapodcast/episodes/2025-12-13T00_42_35-08_00
AUDIO ONLY VERSION
Atiyyah Ferouz – The Great Compliance Gap: Australia’s Regulations vs The Rest of the World
Founder, ICQSA & AgCann
International Cannabis Quality Standards Association
Transitioning to the cannabis industry in 2018, I have spent the past 7 years finding ways to drive the industry forward, whether it’s educating the newest additions to the cannabis space, consulting producers in emerging markets, or launching an international cannabis quality association. At the ICQSA (International Cannabis Quality Standards Association) we are focused on the globalization of the cannabis supply chain. Our association contributes to this mission through the development of best practice guides and the advisement of policymakers in emerging markets. At AgCann, our goal is to help cannabis producers bridge the gap between where they are, and where they want to be. We utilize our expertise in operations, quality assurance, and tissue culture to help producers develop or optimize their processes. In addition to my entrepreneurial efforts, I am an active thought leader in the cannabis space, frequently participating in webinars, workshops, and speaking at global cannabis events.
Timeline
01:08: Start – Introduction AG Consultancy – ICQSA
03:35: Globalised Cannabis Sector – Import / Export
05:33: Australia – Potential , Good Health System . TGA, agricultural sector exports – Ideal for cannabis especially because of bio-security laws – quality branding
07:30: Cannabis compliance alphabet soup
GACP around the world
GMP EU/TGA/ASEAN/SAPHRA etc
09:40: Canadian regulatory landscape – import restrictions / heavy exporter
11:50: Thailand regulatory landscape – move to medical – more rules to improve export market
14:50 Germany regulatory landscape – quotas – lack of domestic production – security requirements – general pharmacies & handling product – GACP/GMP
17:40: Australia’s medical market – no rules on quality of imports – domestic production low – exports low – Australia lagging reasons why – slowest licensing on the planet & complex,
regulatory burdens – unclear guidance federal & state – labelling inconsistent no clear guidelines from government – reporting adverse events a nightmare – microbial rules – irradiation – product choice & access – legalize with prejudice – No domestic GACP programme – GMP in Australia – Impact oll prior items. Australia being flooded with low quality products, slow at innovation
29:30: Atiyyah’s solutions – ideas & thoughts
30:00: Harmonizing standards around the world – ICQSA working groups advise industry & govt
31:00: Thoughts from floor
31:30 End
[ad_2]
Sean Hocking
Source link